The Biopharmaceutical CMO Market size was valued at USD 30.22 billion in 2022 and is expected to reach USD 79.77 billion by 2030 with a growing CAGR of 12.9% over the forecast period of 2023-2030.The biopharmaceutical Contract Manufacturing Organization (CMO) market is experiencing robust growth driven by the increasing demand for biologics and biosimilars, advancements in bioprocessing...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian